Invitation to Participate in HELIO
"AI Use in Life Sciences Compliance" Survey


  • HELIO has launched a new survey named "AI Use in Life Sciences Compliance"
  • Final date for participation in the survey is February 20, 2026
  • Email info@heliogrp.com for Link to take the Survey

    CONTACT:
    Manny Tzavlakis
    Managing Partner | HELIO
    89 Headquarters Plaza North, #1443 | Morristown, NJ 07960
    (m) 201.966.9656 | (e) mtzavlakis@heliogrp.com

MORRISTOWN NJ, USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- FEBRUARY 10, 2026: Helio Health Group ("HELIO") has launched a new survey named "AI Use in Life Sciences Compliance". Participation has been very high so far, and HELIO is looking to grab additional responses for better final results.

Should you like to participate, please email at info@heliogrp.com and they will provide you a link to take the survey. Final date for participation in the survey is February 20, 2026.

The goal of this work is to help the industry better understand what is actually happening on the ground: where AI is being used, how organizations are thinking about oversight and governance, and how practices are evolving in response to both innovation and regulatory expectations. As a participant, HELIO will share the outcomes of the survey with you if you so choose. As always, the results will be shared in an aggregated, anonymized way.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: listmgr@HealthCareUpdateNewsService.com.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.